VIRI News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

Weidai

Boston Scientific

CarMax

Studio City International Holdings

Virios Therapeutics (VIRI) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: September 27, 2023 (11:13)

Sector: Healthcare

The share price of Virios Therapeutics, Inc. (VIRI) now

What analysts predict: $3.5

52-week High/Low: $2.42 / $0.219

50/200 Day Moving Average: $1.549 / $0.842

This figure corresponds to the Average Price over the previous 50/200 days. For Virios Therapeutics stocks, the 50-day moving average is the resistance level today.

For Virios Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Virios Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Virios Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Virios Therapeutics share be worth in 2023 - 2027?

When should I take profit in Virios Therapeutics stock? When should I record a loss on Virios Therapeutics stock? What are analysts' forecasts for Virios Therapeutics stock? What is the future of Virios Therapeutics stock? We forecast Virios Therapeutics stock performance using neural networks based on historical data on Virios Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Virios Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Virios Therapeutics shares. This happens once a day.

Historical and forecast chart of Virios Therapeutics stock

The chart below shows the historical price of Virios Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Virios Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Subscribe for Forecasts Update!

Virios Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Sep 29	0.35	0.34	0.35	3.79
Sep 30	0.35	0.34	0.35	4.31
Oct 01	0.35	0.34	0.35	2.59
Oct 02	0.34	0.33	0.35	4.46
Oct 03	0.35	0.34	0.36	5.53
Oct 04	0.36	0.36	0.37	3.29
Oct 05	0.36	0.35	0.36	2.72
Oct 06	0.36	0.36	0.37	4.58
Oct 07	0.35	0.34	0.35	4.03
Oct 08	0.34	0.34	0.35	3.06
Oct 09	0.33	0.32	0.34	3.14
Oct 10	0.33	0.32	0.33	3.01
Oct 11	0.33	0.32	0.33	3.62
Oct 12	0.33	0.32	0.33	4.51
Oct 13	0.32	0.31	0.33	5.53
Oct 14	0.32	0.32	0.33	2.31
Oct 15	0.32	0.31	0.32	3.05
Oct 16	0.31	0.31	0.32	2.22
Oct 17	0.30	0.29	0.31	5.54
Oct 18	0.30	0.29	0.30	4.90
Oct 19	0.29	0.29	0.30	4.38
Oct 20	0.30	0.29	0.30	3.09
Oct 21	0.29	0.29	0.30	2.68
Oct 22	0.29	0.29	0.30	3.52
Oct 23	0.29	0.28	0.30	5.61
Oct 24	0.29	0.28	0.30	5.12
Oct 25	0.28	0.28	0.29	4.42
Oct 26	0.28	0.28	0.29	3.79
Oct 27	0.29	0.28	0.29	3.05
Oct 28	0.29	0.28	0.29	3.00

Virios Therapeutics Daily Price Targets

Virios Therapeutics Stock Forecast 09-29-2023.

Forecast target price for 09-29-2023: $0.35.
Positive dynamics for Virios Therapeutics shares will prevail with possible volatility of 3.649%.
Pessimistic target level: 0.34
Optimistic target level: 0.35

Virios Therapeutics Stock Forecast 09-30-2023.

Forecast target price for 09-30-2023: $0.35.
Negative dynamics for Virios Therapeutics shares will prevail with possible volatility of 4.130%.
Pessimistic target level: 0.34
Optimistic target level: 0.35

Virios Therapeutics Stock Forecast 10-01-2023.

Forecast target price for 10-01-2023: $0.35.
Negative dynamics for Virios Therapeutics shares will prevail with possible volatility of 2.523%.
Pessimistic target level: 0.34
Optimistic target level: 0.35

Virios Therapeutics Stock Forecast 10-02-2023.

Forecast target price for 10-02-2023: $0.34.
Negative dynamics for Virios Therapeutics shares will prevail with possible volatility of 4.268%.
Pessimistic target level: 0.33
Optimistic target level: 0.35

Virios Therapeutics Stock Forecast 10-03-2023.

Forecast target price for 10-03-2023: $0.35.
Positive dynamics for Virios Therapeutics shares will prevail with possible volatility of 5.236%.
Pessimistic target level: 0.34
Optimistic target level: 0.36

Virios Therapeutics Stock Forecast 10-04-2023.

Forecast target price for 10-04-2023: $0.36.
Positive dynamics for Virios Therapeutics shares will prevail with possible volatility of 3.184%.
Pessimistic target level: 0.36
Optimistic target level: 0.37

VIRI (VIRI) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Oct.	0.31	0.28	0.32	11.58
Nov.	0.29	0.26	0.32	18.66
Dec.	0.27	0.24	0.28	13.33

Full forecast for 2023

Virios Therapeutics forecast for this year

Virios Therapeutics Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $0.308759. Pessimistic: $0.28. Optimistic: $0.32

Virios Therapeutics Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $0.292333. Pessimistic: $0.26. Optimistic: $0.32

Virios Therapeutics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $0.27187. Pessimistic: $0.24. Optimistic: $0.28

Virios Therapeutics (VIRI) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.26	0.23	0.27	13.16
Feb	0.25	0.23	0.26	12.34
Mar	0.24	0.21	0.25	16.01
Apr	0.25	0.22	0.26	15.29
May	0.26	0.23	0.29	18.93
Jun	0.26	0.24	0.28	15.17
Jul	0.23	0.21	0.25	16.22
Aug	0.22	0.20	0.23	13.42
Sep	0.20	0.20	0.21	6.64
Oct	0.20	0.20	0.22	9.61
Nov	0.23	0.20	0.25	19.03
Dec	0.24	0.22	0.25	14.99

Full forecast for 2024

Virios Therapeutics (VIRI) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.23	0.20	0.25	18.83
Feb	0.22	0.20	0.23	10.17
Mar	0.21	0.19	0.21	10.96
Apr	0.23	0.21	0.25	14.77
May	0.21	0.20	0.22	9.66
Jun	0.21	0.19	0.22	13.68
Jul	0.21	0.20	0.23	12.62
Aug	0.21	0.19	0.22	13.92
Sep	0.21	0.18	0.22	14.36
Oct	0.22	0.20	0.23	13.65
Nov	0.23	0.22	0.24	9.51
Dec	0.25	0.24	0.28	12.16

Full forecast for 2025

Virios Therapeutics (VIRI) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.24	0.22	0.26	15.38
Feb	0.24	0.22	0.25	12.06
Mar	0.22	0.20	0.23	16.57
Apr	0.22	0.20	0.24	12.98
May	0.21	0.20	0.22	11.08
Jun	0.24	0.23	0.25	11.25
Jul	0.25	0.24	0.26	9.45
Aug	0.27	0.27	0.29	8.96
Sep	0.30	0.27	0.32	15.10
Oct	0.29	0.26	0.31	15.95
Nov	0.32	0.31	0.34	8.44
Dec	0.36	0.33	0.37	11.58

Full forecast for 2026

Virios Therapeutics (VIRI) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.38	0.35	0.39	11.83
Feb	0.41	0.38	0.45	16.17
Mar	0.42	0.38	0.44	13.58
Apr	0.41	0.39	0.43	8.32
May	0.40	0.39	0.43	9.75
Jun	0.39	0.37	0.42	13.00
Jul	0.41	0.38	0.42	10.49
Aug	0.39	0.38	0.43	12.13
Sep	0.41	0.38	0.42	11.37
Oct	0.40	0.36	0.43	15.58
Nov	0.38	0.35	0.40	11.86
Dec	0.37	0.34	0.38	9.59

Full forecast for 2027

Virios Therapeutics information and performance

Virios Therapeutics is a clinical stage biopharmaceutical company that develops and commercializes innovative antiviral drugs for the treatment of diseases associated with abnormal immune responses caused by viruses, such as fibromyalgia (FM).

Virios Therapeutics Address

44 MILTON AVENUE, ALPHARETTA, GA, US

Market Capitalization: 20 787 200 $

Market capitalization of the Virios Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of VIRI shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA of Virios Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.37

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.578

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 19247400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Zynex, Inc. (ZYXI)

Nano-X Imaging Ltd. (NNOX)

Immuron Limited (IMRN)

Doximity, Inc. (DOCS)

Trevi Therapeutics, Inc. (TRVI)

SCYNEXIS, Inc. (SCYX)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/VIRI.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/VIRI.svg"> Virios Therapeutics (VIRI) Stock Forecast for 2023 – 2026. Sell or Buy?